StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)

Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%

Oramed Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Oramed Pharmaceuticals's price to book ratio was 0.8× on Apr 30, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.5× to 9.8×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.8×+0.2
2025Dec 31, 20250.6×−0.0
2024Dec 31, 20240.6×−0.0
2023Dec 29, 20230.6×−3.0
2022Dec 30, 20223.7×−0.7
2021Dec 31, 20214.4×+1.3
2020Dec 31, 20203.1×−1.6
2019Dec 31, 20194.6×+2.9
2018Dec 31, 20181.7×−4.7
2017Dec 29, 20176.4×+3.3
2016Dec 30, 20163.1×−0.9
2015Dec 31, 20154.0×+1.8
2014Dec 31, 20142.2×−12.8
2013Dec 31, 201315.1×+8.1
2012Dec 31, 20127.0×+1.7
2011Dec 30, 20115.3×–

More Oramed Pharmaceuticals figures

See a number that looks wrong?